FOR IMMEDIATE RELEASE

CONTACTS:

Investors — Scott Pond (801) 345-2657, spond@nuskin.comMedia — Kara Schneck (801) 345-2116, kschneck@nuskin.com

NU SKIN ENTERPRISES REPORTS RECORD THIRD-QUARTER RESULTS

AND RAISES 2013 GUIDANCE

PROVO, Utah — Oct. 22, 2013 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced record third-quarter results with revenue of $927.6 million, a 76 percent increase over the prior-year period. Revenue was negatively impacted 3 percent by foreign currency fluctuations. Earnings per share for the quarter were $1.80, a 107 percent year-over-year improvement.

Additionally, the company announced that it is significantly increasing its full-year 2013 revenue guidance to $3.18 billion to $3.21 billion. The new guidance includes a projected negative currency impact of 4 percent for the year. The company now expects 2013 earnings to be $5.77 to $5.82 per share.

"We are extremely pleased with our third-quarter results," said Truman Hunt, president and chief executive officer. "The momentum we have established in the first half of the year has accelerated as we posted gains throughout the world, with particularly impressive results in the Greater China and South Asia/Pacific regions, as well as South Korea.

"We are delighted to see such a tremendous response to the initial introduction of our ageLOC TR90 weight management system. We began the limited-time-offer of the TR90 system in September, starting in the Greater China and South Asia/Pacific regions and generated approximately $205 million in limited-time-offer sales in the quarter. We expect this momentum to continue through the fourth quarter as the rest of our regions participate in this global limited-time offer."

-more-

Nu Skin Enterprises, Inc.

Oct. 22, 2013

Page 2

Regional Results

Greater China. In Greater China, third-quarter revenue increased 240 percent to $464.6 million, compared to $136.6 million in the prior-year period. The region's results were positively impacted 9 percent by foreign currency fluctuations. Regional revenue included $157.9 million from limited-time-offer (LTO) sales in the third quarter, while the prior year included $20.8 million in LTO revenue. The sales leader count in the region improved 255 percent, while the number of actives increased 123 percent compared to the prior year.

North Asia. Third-quarter revenue in North Asia increased 11 percent to $204.7 million, compared to $184.7 million for the same period in 2012. The region's results were negatively impacted 12 percent by foreign currency fluctuations. Japan local-currency revenue declined 3 percent while South Korea generated local-currency revenue growth of 71 percent. The number of sales leaders in the region was up 15 percent and the number of actives improved 28 percent.

South Asia/Pacific. Revenue in South Asia/Pacific was $127.5 million, a 40 percent improvement compared to the prior year. The region's results included $45.9 million from LTO sales in the third quarter, while the prior-year included $29.3 million in LTO revenue. The region's results were negatively impacted 6 percent by foreign currency fluctuations. The region's third-quarter sales leader count improved 58 percent and actives increased 19 percent compared to the same period in 2012.

Americas. Revenue in the Americas improved 22 percent over the prior-year period to $85.7 million. The region's results were negatively impacted 7 percent by foreign currency fluctuations. The number of sales leaders in the region improved 28 percent and the number of actives increased 8 percent compared to the prior year.

-more-

Nu Skin Enterprises, Inc.

Oct. 22, 2013

Page 3

EMEA. Revenue in the EMEA region increased 4 percent to $45.1 million, primarily as a result of foreign currency fluctuations. The number of sales leaders declined 5 percent while actives increased 2 percent, compared to the prior year.

Operational Performance

The company's operating margin improved to 18.1 percent for the quarter, compared to 15.7 percent in the prior year, as a result of strong LTO sales. Gross margin during the quarter was 84.9 percent, 140 basis points above the prior year, due primarily to the TR90 launch in Greater China and South Asia/Pacific. Selling expenses, as a percent of revenue, were 49.3 percent in the third quarter, compared to 44.8 percent in the prior-year period. The increase was a result of the successful execution of the LTO, driving sales and selling expenses higher as sales leaders qualified for promotional incentives and a higher commission level. General and administrative expenses, as a percent of revenue, were 17.5 percent, a significant improvement from 23.1 percent reported in the prior-year.

The company's income tax rate for the quarter was 34.3 percent compared to 35.2 percent in the prior-year period. The company's cash and short-term investment position at the end of the quarter was $566 million. Dividend payments during the quarter were $17.8 million, and the company repurchased $76 million of its outstanding shares.

Outlook

"Our optimism is a product of robust sales force growth and our innovative product portfolio," said Hunt. "Our sales force has built strong consumer demand for our ageLOC TR90 system, with a very positive initial response to our product release. We continue to improve our execution as we strategically develop and launch innovative products, ensuring a vibrant business opportunity for our sales leaders.

"We have high expectations for our business in the fourth quarter and in 2014 as we continue to execute the rollout of TR90. More than 15,000 people will join us in Salt Lake City this week for our bi-annual global convention. We also look forward to sharing our business plan and financial projections for 2014 at our analyst day on Nov. 21." Hunt concluded.

-more-

Nu Skin Enterprises, Inc.

Oct. 22, 2013

Page 4

"Given the tremendous quarter, as well as our outlook for the remainder of the year, we are significantly raising our 2013 guidance," said Ritch Wood, chief financial officer. "We project the fourth quarter will be our first billion-dollar quarter, with anticipated revenue of $1.02 to $1.05 billion. We estimate a negative currency impact of approximately 6 percent in the fourth quarter, with projected earnings per share of $1.85 to $1.90.This forecast includes projected sales of TR90 in the fourth quarter of approximately $350 million."

The company's management will host a webcast with the investment community on Oct. 22, 2013, at 11 a.m. EDT. Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on Nu Skin Enterprises' website, http://ir.nuskin.com. An archive of the webcast will be available at this same URL through Nov. 8, 2013.

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company's anti-aging products feature the new ageLOC^® suite of products including the ageLOC^® R² nutritional supplement, ageLOC^® Galvanic Spa System and ageLOC^® Galvanic Body Spa™, as well as the ageLOC^® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskin.com.

-more-

Nu Skin Enterprises, Inc.

Oct. 22, 2013

Page 5

Please Note: This press release, particularly the "Outlook" section, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, initiatives, strategies and new product introductions; statements of projections regarding revenue, operating margin, earnings per share, foreign currency impact and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

· any failure of current or planned initiatives or products to generate interest among distributors and customers and generate sponsoring and selling activities on a sustained basis;

· risks associated with rapid growth globally, which could strain our ability to effectively manage our operations, and result in, among other things, product delays or shortages, operating mistakes and errors, inadequate customer service, inappropriate claims or promotions by our sales force, and governmental inquires and investigations, all of which could harm our revenue and ability to generate sustained growth and result in unanticipated expenses.

· risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, including possible ingredient supply limitations;

· risk of foreign currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;

· unpredictable economic conditions and events globally;

· continued regulatory scrutiny and investigations in Mainland China, which have from time to time in the past, and could in the future, negatively impact the company's business, including the interruption of sales activities in stores, loss of licenses, and the imposition of fines;

· risks associated with general inquiries and complaints to consumer protection agencies in Japan regarding the activities of some distributors;

· regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;

· adverse publicity related to the company's business, products, industry or any legal actions or complaints by distributors or others;

· any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and

· continued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

-more-

Nu Skin Enterprises, Inc.

Oct. 22, 2013

Page 6

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Third Quarters Ended September 30, 2013 and 2012
(in thousands, except per share amounts)
	2013		2012
Revenue:
Greater China	$	464,605	$	136,633
North Asia		204,714		184,743
South Asia/Pacific		127,545		91,124
Americas		85,654		70,479
EMEA		45,094		43,203
Total revenue		927,612		526,182
Cost of sales		139,816		86,768
Gross profit		787,796		439,414
Operating expenses:
Selling expenses		456,975		235,701
General and administrative expenses		162,546		121,346
Total operating expenses		619,521		357,047
Operating income		168,275		82,367
Other income (expense), net		504		1,239
Income before provision for income taxes		168,779		83,606
Provision for income taxes		57,879		29,430
Net income	$	110,900	$	54,176
Net income per share:
Basic	$	1.89	$	0.91
Diluted	$	1.80	$	0.87
Weighted average common shares outstanding:
Basic		58,661		59,780
Diluted		61,508		62,060

-more-

Nu Skin Enterprises, Inc.

Oct. 22, 2013

Page 7

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Nine-Month Periods Ended September 30, 2013 and 2012
(in thousands, except per share amounts)
	2013			2012
Revenue:
Greater China	$	909,457		$	428,972
North Asia		589,664			544,638
South Asia/Pacific		280,703			266,789
Americas		246,484			208,585
EMEA		134,325			132,435
Total revenue		2,160,633			1,581,419
Cost of sales		341,134			258,108
Gross profit		1,819,499			1,323,311
Operating expenses:
Selling expenses		1,007,627			705,599
General and administrative expenses		446,355			365,770
Total operating expenses		1,453,982			1,071,369
Operating income		365,517			251,942
Other income (expense), net		(571	)		1,505
Income before provision for income taxes		364,946			253,447
Provision for income taxes		125,329			91,035
Net income	$	239,617		$	162,412
Net income per share:
Basic	$	4.09		$	2.65
Diluted	$	3.91		$	2.55
Weighted average common shares outstanding:
Basic		58,544			61,265
Diluted		61,234			63,742

-more-

Nu Skin Enterprises, Inc.

Oct. 22, 2013

Page 8

NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
(in thousands)
	September 30, 2013			December 31, 2012
ASSETS
Current assets:
Cash and cash equivalents	$	553,499		$	320,025
Current investments		12,099			13,378
Accounts receivable		50,506			36,850
Inventories, net		254,187			135,874
Prepaid expenses and other		143,066			93,276
		1,013,357			599,403
Property and equipment, net		352,709			229,787
Goodwill		112,446			112,446
Other intangible assets, net		85,901			92,518
Other assets		124,074			118,753
Total assets	$	1,688,487		$	1,152,907
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	67,516		$	47,882
Accrued expenses		572,432			233,202
Current portion of long-term debt		68,562			39,019
		708,510			320,103
Long-term debt		120,606			154,963
Other liabilities		116,942			87,229
Total liabilities		946,058			562,295
Stockholders' equity:
Class A common stock		91			91
Additional paid-in capital		357,701			317,293
Treasury stock, at cost		(788,128	)		(714,853	)
Retained earnings		1,226,629			1,039,903
Accumulated other comprehensive loss		(53,864	)		(51,822	)
		742,429			590,612
Total liabilities and stockholders' equity	$	1,688,487		$	1,152,907

-more-

Nu Skin Enterprises, Inc.

Oct. 22, 2013

Page 9

NU SKIN ENTERPRISES, INC. Actives/Sales Leaders Statistics
	As of September 30, 2013				As of September 30, 2012				% Increase (Decrease)
	Actives		Sales Leaders		Actives		Sales Leaders		Actives		Sales Leaders
Greater China		418,000		57,780		188,000		16,269		122.3%		255.2%
North Asia		430,000		17,994		336,000		15,603		28.0%		15.3%
South Asia/Pacific		125,000		9,280		105,000		5,880		19.0%		57.8%
Americas		179,000		7,461		166,000		5,831		7.8%		28.0%
EMEA		121,000		4,375		118,000		4,581		2.5%		(4.5%)
Total		1,273,000		96,890		913,000		48,164		39.4%		101.2%

"Actives" are persons who purchased products directly from the company during the three months ended as of the date indicated.

"Sales Leaders" include our independent distributors who have completed and who maintain specified sales requirements, and our sales employees and contractual sales promoters in China, who have completed certain qualification requirements.